Medical Care Technologies Inc. Powers Forward in 2025
In a remarkable display of resilience and innovation, Medical Care Technologies Inc. (OTC Pink: MDCE) is experiencing a significant rebound in 2025. The company, known for its development-stage operations in children’s integrated health and wellness centers in China, is now making waves with its subsidiaries’ explosive growth and groundbreaking technological advancements.
Record-Breaking Revenue Growth
The company’s Q2 2025 revenue surged by an astonishing 2,500% year-over-year, a testament to its strategic initiatives and innovative products. This momentum is expected to continue into Q3, with projections indicating that performance could surpass previous results. At the heart of this resurgence is MDCE’s proprietary AI imaging system, which is currently patent-pending (U.S. Provisional Patent Application No. 63/854,935). This technology not only enhances medical diagnostic imaging but also serves as a powerful tool for AI-driven authentication of high-value collectibles.
Three Pillars of Growth
MDCE’s growth is driven by three key subsidiaries:
Medical Care Technologies: Focused on developing smartphone-based AI diagnostic tools, this subsidiary aims to revolutionize real-time healthcare monitoring and early disease detection.
Real Game Used: Specializing in AI-powered authentication and photo-match verification, this subsidiary caters to the sports and entertainment memorabilia market, ensuring the authenticity of high-value items.
Infinite Auctions: As a premier auction house, Infinite Auctions is currently showcasing “The Grail Collection,” an unprecedented offering of historic memorabilia, including iconic game-worn items from legends like Michael Jordan.
Strategic Corporate Restructuring
In addition to its impressive revenue growth, MDCE is preparing for a major share reduction and corporate restructuring. Following the successful onboarding of a new transfer agency, the company is set to execute its restructuring plan, which aims to create a leaner and more efficient capital structure. This move is designed to enhance long-term shareholder value and complement the strong momentum driven by its subsidiaries.
Leadership and Future Outlook
Marshall Perkins III, CEO of Medical Care Technologies Inc., expressed optimism about the company’s trajectory. “We are very encouraged by the growth of our subsidiaries and equally proud to advance the restructuring process through the onboarding of our new transfer agent,” he stated. With a market cap of $661,920 and a close price of $0.0003 as of August 20, 2025, MDCE is poised for continued success, leveraging its innovative technologies and strategic initiatives to drive future growth.
As MDCE continues to bridge healthcare and culture through applied innovation, investors and industry observers will be keenly watching its progress in the coming months. With its forward-looking strategies and robust growth engines, Medical Care Technologies Inc. is well-positioned to capitalize on emerging opportunities in both the healthcare and collectibles markets.